American Century Companies Inc. trimmed its position in MedEquities Realty Trust (NYSE:MRT) by 0.3% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,105,216 shares of the financial services provider’s stock after selling 6,117 shares during the quarter. American Century Companies Inc. owned about 6.60% of MedEquities Realty Trust worth $22,126,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. LSV Asset Management purchased a new stake in MedEquities Realty Trust in the 4th quarter worth approximately $103,000. JPMorgan Chase & Co. purchased a new stake in MedEquities Realty Trust in the 3rd quarter worth approximately $118,000. MetLife Investment Advisors LLC purchased a new stake in MedEquities Realty Trust in the 4th quarter worth approximately $120,000. Raymond James Financial Services Advisors Inc. increased its holdings in MedEquities Realty Trust by 89.0% in the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 25,012 shares of the financial services provider’s stock worth $281,000 after acquiring an additional 11,778 shares in the last quarter. Finally, Municipal Employees Retirement System of Michigan purchased a new stake in MedEquities Realty Trust in the 4th quarter worth approximately $335,000. 89.09% of the stock is owned by institutional investors.

Shares of MRT opened at $10.39 on Friday. MedEquities Realty Trust has a 1 year low of $10.27 and a 1 year high of $10.43. The company has a market cap of $326.84 million, a price-to-earnings ratio of 9.11 and a beta of -0.18.

MedEquities Realty Trust (NYSE:MRT) last announced its quarterly earnings data on Thursday, May 10th. The financial services provider reported $0.16 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.30 by ($0.14). MedEquities Realty Trust had a net margin of 34.63% and a return on equity of 6.17%. The company had revenue of $16.72 million for the quarter, compared to analysts’ expectations of $16.41 million. equities research analysts anticipate that MedEquities Realty Trust will post 1.2 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 5th. Shareholders of record on Tuesday, May 22nd will be issued a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 8.08%. The ex-dividend date of this dividend is Monday, May 21st. MedEquities Realty Trust’s dividend payout ratio (DPR) is currently 73.68%.

Several research firms recently issued reports on MRT. ValuEngine lowered shares of MedEquities Realty Trust from a “hold” rating to a “sell” rating in a report on Wednesday, May 2nd. B. Riley set a $13.00 target price on shares of MedEquities Realty Trust and gave the stock a “buy” rating in a report on Thursday, February 22nd. KeyCorp reduced their target price on shares of MedEquities Realty Trust from $13.00 to $12.00 and set an “overweight” rating for the company in a report on Monday, April 16th. JMP Securities set a $13.00 target price on shares of MedEquities Realty Trust and gave the stock a “buy” rating in a report on Friday, May 11th. Finally, Cantor Fitzgerald reissued a “buy” rating and issued a $14.00 target price on shares of MedEquities Realty Trust in a report on Wednesday, February 21st. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $12.43.

In other MedEquities Realty Trust news, Director Bluemountain Capital Managemen sold 17,674 shares of the stock in a transaction that occurred on Friday, May 4th. The shares were sold at an average price of $10.16, for a total transaction of $179,567.84. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Over the last ninety days, insiders have sold 235,786 shares of company stock valued at $2,435,627. Insiders own 2.50% of the company’s stock.

About MedEquities Realty Trust

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Institutional Ownership by Quarter for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.